Eastern Financiers‘ Head of Research Rajesh Agarwal recommended selling Ranbaxy Labs. He said he wouldn‘t be surprised if this stock falls below Rs 350 in next three months.
first published: May 23, 2013 05:33 pm
A collection of the most-viewed Moneycontrol videos.
Nifty On Track To End Week Above 25,500 As Bank & Metal Stocks Lead Rebound| Closing Bell Live
Can Nifty Stage A Friday Fightback After Hitting 3-Week Low? Pine Labs IPO Opens | Opening Bell Live
Nifty Stays Below 25,600 Amid Expiry-Led Volatility; Grasim, Hindalco In Focus| Closing Bell Live
Pine Labs’ Rs 3,900 Cr IPO| CEO Amrish Rau On Why The Issue Size Was Cut & The Post-IPO Gameplan
